Fourth-year students of the EPP “Biotechnologies: Pharmaceutical, Industrial, Food, and Environmental” had a unique opportunity, within the framework of the elective course “Technology of Probiotics and Vaccines,” to attend a guest lecture by a member of the academic community and a practicing specialist — Doctor of Biological Sciences, Leading Research Fellow of the Department of Interferon and Immunomodulators Problems, Deputy Director for Research of the D.K. Zabolotny Institute of Microbiology and Virology of the National Academy of Sciences of Ukraine, Liudmyla Mykolaivna Lazarenko, who gladly accepted the invitation of the course lecturer Svitlana Starovoitova. Ms. Liudmyla presented her own scientific work in the field of developing probiotics for the treatment of vaginitis and shared the results of her own experimental research.
The bachelor’s students were left utterly delighted with Liudmyla Lazarenko’s lecture:
Anna Kosiak (BT-4-1): “Inviting guests to lectures and seminars within academic courses proves to be an extremely useful practice that helps enrich the educational process and increase the exchange of knowledge and experience among participants. That is why, for the lecture held on 16 April 2024 within the course “Technologies of Probiotics and Vaccines,” Svitlana Oleksandrivna Starovoitova invited a very interesting speaker, Doctor of Biological Sciences, Deputy Director for Research of the D.K. Zabolotny Institute of Microbiology and Virology of the National Academy of Sciences of Ukraine, Liudmyla Mykolaivna Lazarenko.
The main topic of the lecture was the study of the immunomodulatory and anti-inflammatory action of bacteria in vaginitis in mice. This subject proved to be extremely fascinating and useful for us in understanding the importance of the microbiota for health, and within the framework of the course, in my opinion, the role of probiotics in the prevention and treatment of diseases is also important — probiotics that are, in turn, developed on the basis of the commensal microbiota of human mucous membranes. This discovery will increase the effectiveness of treating infectious-inflammatory diseases through a better response of the body to the drug.
We are sincerely grateful to our lecturer for inviting such an excellent speaker. Her presentation was a true enrichment of our understanding of the scientific aspects that are of great importance for our professional and personal cognitive activity!”
Mariia Hodlevska (BT-4-3): “I had the opportunity to attend the invited speaker’s lecture on the topic of developing probiotics for the treatment of vaginitis. This topic proved to be exceptionally fascinating for us, since we are always interested in innovative treatment methods and the use of biotechnologies to improve health.
Liudmyla Lazarenko, a research fellow of the Institute of Microbiology and Virology, described the problem of vaginitis in considerable detail and highlighted the potential advantages of using probiotics in its treatment. She explained that vaginitis can be caused by an imbalance of the microflora of the vaginal tract, and in this context probiotics may prove to be an effective treatment method.
As for the characterization of strains of lacto- and bifidobacteria, attention was drawn to their great importance in developing probiotics for vaginal application. The strains that were demonstrated to us possess optimal properties for combating pathogenic flora and restoring a healthy microbiota.
We especially appreciated the detailed analysis of the principles of action of probiotics and their advantages compared with traditional methods of treating vaginitis. This opened up new prospects for us in the use of biotechnologies for developing effective medicinal products.
In summary, this video meeting became an important source of information for our cohort, one that inspired us toward further research in the field of probiotic development. Innovative approaches to this problem open up new opportunities for improving patients’ quality of life and preserving health.”
Olha Rybnikova (BT-4-3): “The guest lecture was devoted to the topic of developing probiotics for the treatment of vaginitis. The lecturer began by giving a definition of vaginitis and describing its symptoms. She then discussed the various types of vaginitis and their causes. She explained that vaginitis can arise for various reasons, including an imbalance of the vaginal microflora.
The action of probiotics consists in restoring the balance of “beneficial” bacteria in the vaginal microflora, which helps to combat pathogenic microorganisms.
The main theme and objective was to develop probiotics based on the commensal microbiota with antibacterial, immunomodulatory, and anti-inflammatory action for the treatment of vaginitis. In discussing the relevance of this development, it became clear that the use of probiotics with a multifactorial action aimed at restoring the microbiota of various biotopes, normalizing inflammation and the immune response without side effects that are difficult to predict and compensate for in each specific case, will result in increased effectiveness of the prevention of infectious-inflammatory diseases and of personalized treatment.
The lecturer presented the results of her own experimental research confirming the effectiveness of probiotics in the treatment of vaginitis. She also noted that some types of probiotics may be especially useful for specific groups of women, such as those with reduced immunity or those suffering from chronic diseases.
From the lecture I understood that, with the aim of developing fundamentally new methods for the prevention of infectious-inflammatory diseases of the vagina and the treatment of patients, the development of modern medicine is moving along the path of using natural, harmless preparations — probiotics created, in particular, on the basis of the commensal microbiota of human mucous membranes.”
Diana Hrebelna (BT-4-3): “During the lecture for the course “Technology of Probiotics and Vaccines,” we had the opportunity to attend a guest lecture on the topic “Developing Probiotics for the Treatment of Vaginitis” by senior research fellow of the Institute of Microbiology and Virology Liudmyla Lazarenko.
We were told what vaginitis is and about its symptoms. We learned that vaginitis can arise for various reasons.
The main goal was to develop probiotics based on the commensal microbiota with antibacterial, immunomodulatory, and anti-inflammatory action for the treatment of vaginitis.
Experiments were presented to us, namely “The Therapeutic and Antimicrobial Action of Bacteria in Experimental Vaginitis in BALB/C Line Mice.” This study showed that treating bacterial vaginitis in BALB/C line mice led to the disappearance of the clinical signs of the infectious process and the normalization of the cytomorphological structure of the vagina. It was also found that the antimicrobial action was effective in increasing the number of beneficial bacteria and normalizing opportunistic microorganisms in various organs and systems of the body.
The effectiveness of different probiotic bacteria in treating infected vaginitis in mice over different periods of time was compared. The researchers concluded that a different time of onset and degree of normalization of the cytomorphological structure of the vaginal wall was observed depending on the type of probiotic bacteria and the method of their administration.
We also became acquainted with the “Study on the Selection of Excipients and the Determination of Their Influence on the Pharmaco-Technological Properties of Suppositories with Probiotic Activity.”
Studies of experimental vaginitis in mice confirmed the effectiveness of the treatment and the antimicrobial action of probiotics, especially in normalizing the cytomorphological structure of the vagina. Comparing the effectiveness of different probiotic bacteria made it possible to draw a conclusion about their different effects and potential in the treatment of vaginitis. Studies on the selection of excipients for suppositories confirmed the possibility of optimizing the pharmaco-technological properties of probiotics, which opens up new prospects for their use in clinical practice.”
We sincerely thank Liudmyla Mykolaivna for an interesting and informative lecture!







